LLY- Eli Lilly & Co
Eli Lilly & Co (LLY) has 20 insiders with recent SEC Form 4 filings, including 1 buy and 32 sells. LLY is classified in the Pharmaceuticals industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 92.18M | $102.37B | - | |
| CEO | 515.2K | $572.14M | - | |
| VP | 137.5K | $152.69M | - | |
| Dir | 75.1K | $83.41M | - | |
| Dir | 55.5K | $61.60M | - |
Activity
Buys and sells only
Transactions
10 filings · page 12
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 63,572 | $554.38 | $35,243,238.20 | - | +8.6% | +72.1% | |
| Aug 24, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 20,992 | $554.74 | $11,645,029.20 | - | +8.6% | +73.9% | |
| Aug 23, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 1,307 | $555.69 | $726,284.48 | - | +7.1% | +72.4% | |
| Aug 21, 2023 | Zakrowski Donald A | SVP, Finance, &CAO | Sell | 600 | $546.51 | $327,906.00 | -10.0% | +8.6% | +72.7% | |
| Aug 15, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 50,222 | $543.72 | $27,306,747.21 | - | +12.1% | +70.4% | |
| Aug 14, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 164,778 | $539.08 | $88,829,242.94 | - | +13.9% | +68.8% | |
| Aug 11, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 83,039 | $528.50 | $43,886,429.76 | - | +11.9% | +68.8% | |
| Aug 11, 2023 | Eli Lilly & Co | 10% Owner | Buy | 1,718,493 | $14.92 | $25,639,915.56 | -100.0% | +11.9% | +68.8% | |
| Aug 10, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 3,000 | $528.14 | $1,584,405.00 | - | +18.8% | +71.0% | |
| Aug 9, 2023 | Lilly Endowment Inc | 10% Owner | Sell | 123,961 | $528.83 | $65,554,314.24 | - | +14.0% | +60.6% |